6
1
↑0
↓6
—1
Evidence suggests Melatonin maydecreaseBreast cancer.
6 studies (7 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
6 of 8
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| melatonin | Decreases - inhibits the development of | breast cancer | Molecular | — | Not mentioned | Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms.cited 14× |
| melatonin | Decreases - has the potential to prevent metastatic and invasive nature | breast cancer | Human | — | Not specified. | The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.cited 28× |
| melatonin | Decreases - anti-metastatic effect | breast cancer | Human | — | Not specified. | The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor.cited 28× |
| melatonin | Decreases - protective and therapeutic role | breast cancer | HumanMolecular | blind women | Not specified | Protective role of melatonin in breast cancer: what we can learn from women with blindness.cited 2× |
| melatonin | No effect - poorly documented to conclude on a positive effect | breast cancer | HumanMolecular | — | Not specified | Protective role of melatonin in breast cancer: what we can learn from women with blindness.cited 2× |
| melatonin | No effect - will become one of the most common therapeutic drugs | breast cancer | Human | — | — | Molecular and cellular mechanisms of melatonin in breast cancer.cited 9× |